U.S. Markets closed

A Financial Overview of Sangamo Therapeutics in December 2018

Daniel Collins
A Financial Overview of Sangamo Therapeutics in December 2018

Who Is Eyeing Sangamo Therapeutics Now?(Continued from Prior Part)Revenue trends In the first nine months of 2018, Sangamo Therapeutics’ (SGMO) net revenues grew ~145% to reach $57.6 million from $23.